These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up. Boruta DM; Shibley T J Minim Invasive Gynecol; 2016; 23(6):1009-11. PubMed ID: 27393286 [TBL] [Abstract][Full Text] [Related]
24. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe? Hinchcliff EM; Cohen SL Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837 [TBL] [Abstract][Full Text] [Related]
25. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study. Skorstad M; Kent A; Lieng M Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683 [TBL] [Abstract][Full Text] [Related]
26. Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids. Siedhoff MT; Kim KH J Surg Oncol; 2015 Dec; 112(7):769-71. PubMed ID: 26768314 [TBL] [Abstract][Full Text] [Related]
27. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy. Tulandi T; Leung A; Jan N J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909 [TBL] [Abstract][Full Text] [Related]
28. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures. Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993 [TBL] [Abstract][Full Text] [Related]
29. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases. Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy. Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536 [TBL] [Abstract][Full Text] [Related]
31. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations. Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644 [TBL] [Abstract][Full Text] [Related]
32. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation. Ton R; Kilic GS; Phelps JY J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369 [TBL] [Abstract][Full Text] [Related]
33. Three-dimensional transvaginal sonographic assessment of uterine volume as preoperative predictor of need to morcellate in women undergoing laparoscopic hysterectomy. Gerges B; Mongelli M; Casikar I; Bignardi T; Condous G Ultrasound Obstet Gynecol; 2017 Aug; 50(2):255-260. PubMed ID: 27281513 [TBL] [Abstract][Full Text] [Related]
34. Power morcellators: a review of current practice and assessment of risk. Senapati S; Tu FF; Magrina JF Am J Obstet Gynecol; 2015 Jan; 212(1):18-23. PubMed ID: 25072737 [TBL] [Abstract][Full Text] [Related]
35. FDA considers restricting or banning laparoscopic morcellation. Brower V J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25313228 [No Abstract] [Full Text] [Related]
39. AAGL advancing minimally invasive gynecology worldwide: statement to the FDA on power morcellation. Brown J J Minim Invasive Gynecol; 2014; 21(6):970-1. PubMed ID: 25195157 [No Abstract] [Full Text] [Related]
40. Peritoneal nodules after laparoscopic surgery with uterine morcellation: review of a rare complication. Heller DS; Cracchiolo B J Minim Invasive Gynecol; 2014; 21(3):384-8. PubMed ID: 24462597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]